Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Mirati Therapeutics
(NQ:
MRTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
58.85 (1)
Ask (Size)
59.74 (10)
Prev. Close
58.70
Today's Range
N/A - N/A
52wk Range
30.99 - 64.41
Shares Outstanding
51,623,193
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.
Via
Benzinga
EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
December 20, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Performance
More News
Read More
Analyst Expectations For Mirati Therapeutics's Future
December 20, 2023
Via
Benzinga
Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment
November 29, 2023
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
What 11 Analyst Ratings Have To Say About Mirati Therapeutics
November 07, 2023
Via
Benzinga
3 Resilient Stocks with Massive Potential to Boost Your Wealth
November 26, 2023
Via
InvestorPlace
These Three Biotech Stocks Are Trading At A Discount
November 23, 2023
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
November 17, 2023
Via
Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
November 16, 2023
Via
InvestorPlace
MIRATI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mirati Therapeutics, Inc. - MRTX
November 08, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
3 No-Brainer Stocks to Buy With $500 Right Now
November 08, 2023
Via
The Motley Fool
Appian To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Tuesday
November 07, 2023
Via
Benzinga
Is MIRATI THERAPEUTICS INC Ready to Break Out of Its Range?
November 06, 2023
Via
Chartmill
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
October 19, 2023
Via
InvestorPlace
Opdivo's Subcutaneous Formulation Shows Promise in Advanced Kidney Cancer: Bristol Myers Squibb's Latest Findings
October 19, 2023
Via
Benzinga
Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race
October 17, 2023
Via
PressReach
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq – CNSL), Mirati Therapeutics, Inc.® (Nasdaq - MRTX), Pioneer Natural Resources (NYSE - PXD), Summit Materials (NYSE
October 16, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Amgen Stock Surges To 10-Month High, Up 4% On An Unexpected Upgrade
October 11, 2023
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
October 10, 2023
Via
Benzinga
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
October 10, 2023
Via
PressReach
MIRATI THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mirati Therapeutics, Inc. - MRTX
October 09, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
October 09, 2023
Via
Benzinga
Why Shares of Tango Therapeutics Are Dropping Monday
October 09, 2023
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023
October 09, 2023
Via
Benzinga
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 09, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.